Adaptin Bio (APTN) Short term Debt (2024 - 2026)
Adaptin Bio (APTN) reported Short term Debt of $240698.0 for Q1 2026, down 55.83% sequentially from $544957.0 in Q4 2024.
Adaptin Bio (APTN) Short term Debt (2024 - 2026) Analysis & Trends
Adaptin Bio has disclosed Short term Debt across 2 years of filings, most recently posting $240698.0 for Q1 2026.
- Quarterly Short term Debt changed N/A year-over-year to $240698.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $240698.0 (changed N/A YoY) and the FY2024 annual result came in at $544957.0, changed N/A from the prior year.
- Short term Debt eased to $240698.0 in Q1 2026, from $544957.0 in the prior quarter.
- Across five years, Short term Debt topped out at $544957.0 in Q4 2024 and bottomed at $240698.0 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240,698.00 |
| Dec 31, 2024 | 544,957.00 |